XML 21 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities    
Net loss $ (4,577,870) $ (3,312,728)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock option compensation expense 515,959 491,440
Common stock issued for interest and in lieu of salary to officers and fees for services from consultants 504,263 489,107
Interest expense related to amortization of the discount on convertible notes payable and line of credit and deferred financing costs 1,723,396 668,257
Change in derivative liability (321,872)
Amortization and depreciation expense 14,439 5,575
Bad debt expense 15,000
Changes in assets and liabilities:    
Accounts receivable (25,111) (5,275)
Inventories (2,461) 13,555
Prepaid expenses and other current assets (8,706) 5,247
Accounts payable and accrued expenses 144,335 (13,839)
Officer bonus (80,000)
Deposits 50,000 (35,000)
Net cash used in operating activities (2,048,628) (1,693,661)
Cash flows from investing activities    
Equipment purchase (5,500)
Net cash used in investing activities (5,500)
Cash flows from financing activities    
Proceeds from convertible notes 225,000 535,000
Proceeds from line of credit 250,000 300,000
Purchase of Clyra Shares (40,000)
Proceeds from exercise of warrants 153,000
Net cash provided by financing activities 588,000 835,000
Effect of foreign currency translation (15,986) (9,924)
Net change in cash and cash equivalents (1,476,614) (874,085)
Cash and cash equivalents at beginning of period 1,910,153 1,763,114
Cash and equivalents at end of period 433,539 889,029
Supplemental disclosures of cash flow information    
Interest 4,487
Income taxes 5,350 4,000
Non-cash investing and financing activities    
Conversion of accounts payable into stock options 243,824 183,159
Fair value of warrants issued in conjunction with convertible notes payable 225,000 772,405
Settlement of accounts payable and interest into shares of common stock 504,263 489,107
Convertible notes into shares of common stock $ 530,000